367 related articles for article (PubMed ID: 26481868)
1. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of the epigenetic regulator SETDB1 in liver carcinogenesis-more than one way to skin a cat.
Longerich T
Chin Clin Oncol; 2016 Dec; 5(6):72. PubMed ID: 27164857
[TBL] [Abstract][Full Text] [Related]
3. Histone methyltransferase SETDB1 promotes cells proliferation and migration by interacting withTiam1 in hepatocellular carcinoma.
Zhang Y; Huang J; Li Q; Chen K; Liang Y; Zhan Z; Ye F; Ni W; Chen L; Ding Y
BMC Cancer; 2018 May; 18(1):539. PubMed ID: 29739365
[TBL] [Abstract][Full Text] [Related]
4. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
[TBL] [Abstract][Full Text] [Related]
5. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM
Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of zeste homolog 2 promotes hepatocellular cancer progression and chemoresistance by enhancing protein kinase B activation through microRNA-381-mediated SET domain bifurcated 1.
Zhou J; Che J; Xu L; Yang W; Li Y; Zhou W; Zou S
Bioengineered; 2022 Mar; 13(3):5737-5755. PubMed ID: 35184652
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-621 Acts as a Tumor Radiosensitizer by Directly Targeting SETDB1 in Hepatocellular Carcinoma.
Shao Y; Song X; Jiang W; Chen Y; Ning Z; Gu W; Jiang J
Mol Ther; 2019 Feb; 27(2):355-364. PubMed ID: 30503969
[TBL] [Abstract][Full Text] [Related]
8. Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma.
Wang C; Xia Z; Li Z; Ye F; Ji S; Lu C; Zhang H
J Clin Lab Anal; 2022 Jan; 36(1):e24090. PubMed ID: 34843122
[TBL] [Abstract][Full Text] [Related]
9. SETD3 is regulated by a couple of microRNAs and plays opposing roles in proliferation and metastasis of hepatocellular carcinoma.
Xu L; Wang P; Feng X; Tang J; Li L; Zheng X; Zhang J; Hu Y; Lan T; Yuan K; Zhang Y; Ren S; Hao X; Zhang M; Xu M
Clin Sci (Lond); 2019 Oct; 133(20):2085-2105. PubMed ID: 31654063
[TBL] [Abstract][Full Text] [Related]
10. [LncRNA HULC promots HCC growth by downregulating miR-29].
Zhu LR; Feng JL; Liu XJ; Wang JM
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):659-666. PubMed ID: 31550855
[No Abstract] [Full Text] [Related]
11. Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Zhang B; Deng C; Wang L; Zhou F; Zhang S; Kang W; Zhan P; Chen J; Shen S; Guo H; Zhang M; Wang Y; Zhang F; Zhang W; Xiao J; Kong B; Friess H; Zhuge Y; Yan H; Zou X
Mol Carcinog; 2018 Feb; 57(2):201-215. PubMed ID: 29027712
[TBL] [Abstract][Full Text] [Related]
12. A regulatory circuitry comprising TP53,
Chen B; Wang J; Wang J; Wang H; Gu X; Tang L; Feng X
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054425
[TBL] [Abstract][Full Text] [Related]
13. Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
Wang Y; Xie BH; Lin WH; Huang YH; Ni JY; Hu J; Cui W; Zhou J; Shen L; Xu LF; Lian F; Li HP
Oncogene; 2019 Jun; 38(25):4948-4961. PubMed ID: 30842588
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression.
Wang Y; Qin X; Guo T; Liu P; Wu P; Liu Z
J Exp Clin Cancer Res; 2017 Jul; 36(1):97. PubMed ID: 28716136
[TBL] [Abstract][Full Text] [Related]
15. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.
Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ
J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of SETDB1 as a therapeutic target.
Karanth AV; Maniswami RR; Prashanth S; Govindaraj H; Padmavathy R; Jegatheesan SK; Mullangi R; Rajagopal S
Expert Opin Ther Targets; 2017 Mar; 21(3):319-331. PubMed ID: 28076698
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitination of Lysine 867 of the Human SETDB1 Protein Upregulates Its Histone H3 Lysine 9 (H3K9) Methyltransferase Activity.
Ishimoto K; Kawamata N; Uchihara Y; Okubo M; Fujimoto R; Gotoh E; Kakinouchi K; Mizohata E; Hino N; Okada Y; Mochizuki Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Inoue T; Tachibana K; Doi T
PLoS One; 2016; 11(10):e0165766. PubMed ID: 27798683
[TBL] [Abstract][Full Text] [Related]
20. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]